-
Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model2024 European Journal of Cancer article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Hedwig M. Blommestein, Saskia de Groot, Brenda Leeneman, Carin A. Uyl‐de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, +12 more
5citations -
Shared decision-making supported by outcome information regarding surveillance after curative treatment for breast cancer: Results of the SHOUT-BC study2024 European Journal of Cancer article Health Professions Patient-Provider Communication in Healthcare Open access
Jet Wies Ankersmid, Constance H.C. Drossaert, Luc J. A. Strobbe, Mariska Q.N. Hackert, Noel Engels, Janine C. M. Prick, +5 more
5citations -
Patient-led follow-up after curative colorectal cancer surgery: The primary outcome analysis of the prospective, multicentre FUTURE-primary implementation study
M. H. Elise van Driel, Lissa Wullaert, Kelly R. Voigt, Loubna Outmani, Pascal Gabriël Doornebosch, Koen C.M.J. Peeters, +6 more
4citations -
Conference on challenges in sarcoma (CCS) 2024: Expert opinions on non-evidence-based management aspects2025 European Journal of Cancer article Medicine Sarcoma Diagnosis and Treatment Open access cited by 1 patent
Silvia Höfer, Chantal Pauli, Beata Bode‐Lesniewska, Sylvie Bonvalot, Christina Fotopoulou, Hans A. J. Gelderblom, +26 more
4citations -
Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer
Guilhem Roubaud, Gerhardt Attard, Martin Boegemann, David Olmos, Marco Trevisan, Laurent Antoni, +6 more
4citations -
Tumor-stroma ratio is associated with Miller-Payne and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer2020 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Sophie C. Hagenaars, S de Groot, Danielle B. Cohen, Ayoub Charehbili, Tim J. A. Dekker, Elma Meershoek‐Klein Kranenbarg, +6 more
3citations -
Pharmacokinetics and pharmacodynamics of an anti-CSF1 receptor antibody in the intra-articular treatment of tenosynovial giant cell tumor2025 European Journal of Cancer article Medicine Musculoskeletal synovial abnormalities and treatments Open access
Michiel A. J. van de Sande, Kirk W. Johnson, Kirsten van Langevelde, Thomas J. Scharschmidt, Laman Alani, Dorothy Nguyen, +3 more
3citations -
De-escalating treatment for low-risk Ductal Carcinoma In Situ: Early safety of active surveillance without endocrine therapy in the prespecified interim analysis of the LORD-trial* (BOOG 2014-04)2026 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
J. Wesseling, M. Nieberg, S. Aleikhaneshir, Lotte E. Elshof, R. Schmitz, Carine Sondermeijer, +13 more
3citations -
Nine-year survival outcome of neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer (NeoALTTO, BIG 1-06): final analysis of a multicentre, open-label, phase 3 randomised clinical trial.
Paolo Giovanni Nuciforo, John Townend, Cristina Saura, E. de Azumbaja, Florentine Hilbers, Anna Manukyants, +13 more
3citations -
AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response
Mark Schuiveling, Isabella A.J. van Duin, Laurens S. ter Maat, Rik Jasper Verheijden, Franchette W.P.J. van den Berkmortel, Gerben Eise Breimer, +14 more
2citations -
Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry2023 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Jesper van Breeschoten, Alfons J.M. van den Eertwegh, Doranne L. Hilarius, John B.A.G. Haanen, Christian U. Blank, Maureen J.B. Aarts, +14 more
2citations -
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium
Giacomo Giulio Baldi, Claudia Giani, Silva Ljevar, Ryan A. Denu, Andrea Napolitano, Ilkyu Han, +35 more
2citations -
SNP rs10748643 within the promoter region of ENTPD1 (the gene encoding CD39) has no prognostic value in Sézary patients2023 European Journal of Cancer article Medicine Cutaneous lymphoproliferative disorders research Open access
Yixin Luo, Kees Tensen, Willem H. Zoutman, Safa Najidh, Koen D. Quint, Maarten H. Vermeer
2citations